title: Fibronectin and fibrin gel structure.
abstract: Plasma fibronectin is covalently incorporated into alpha-chains of fibrin gels in the presence of Factor XIII activated by thrombin (FXIIIaT) but not by Factor XIII activated by the snake venom enzyme batroxobin (FXIIIaB). FXIIIaB catalyzes introduction of gamma-gamma cross-links in fibrin but cross-linked alpha-chains are not formed. In the presence of FXIIIaT, fibrin gels formed by batroxobin incorporated fibronectin and the alpha-chains are cross-linked indicating that FXIIIaB has a different substrate specificity from FXIIIaT. In the presence of FXIIIaT the incorporation of fibronectin approaches 1 mol/340 kDa unit weight of fibrin. Fibronectin when present in a fibrinogen thrombin mixture containing FXIII does not influence the clotting time of the system nor the release of fibrinopeptides. Incorporation of fibronectin is not appreciable before the gel point. This indicates that the polymerization and gelation of fibrinogen is essentially not perturbed by the presence of fibronectin and that fibrin in the gel matrix rather than the fibrin polymers formed prior to gel point is the preferred structure for fibronectin incorporation. Incorporation of fibronectin into fibrin gels during formation leads to an increase in turbidity and a small decrease in Ks (permeability coefficient). This suggests that the width of the strands in the gel increases as a result of fibronectin incorporation. Fibronectin is also incorporated into preformed gels having completely cross-linked gamma- and alpha-chains perhaps indicating that the sites in fibrin involved in fibronectin incorporation are different from those involved in fibrin cross-linking. FXIIIaT appeared to be adsorbed to fibrin gel matrix in the presence but not in the absence of calcium ions.
authors.forename: M
authors.initials: M
authors.lastname: Okada
authors.forename: B
authors.initials: B
authors.lastname: Blombäck
authors.forename: M D
authors.initials: MD
authors.lastname: Chang
authors.forename: B
authors.initials: B
authors.lastname: Horowitz
mesh_terms: D012103:Batroxobin / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D004591:Electrophoresis, Polyacrylamide Gel; D005176:Factor XIII / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism*; D005340:Fibrinogen / Q000494:pharmacology; D005353:Fibronectins / Q000378:metabolism* / Q000494:pharmacology; D005782:Gels; D006801:Humans; D046911:Macromolecular Substances; D010539:Permeability; D013053:Spectrophotometry; D013917:Thrombin / Q000494:pharmacology; D011503:Transglutaminases
chemical_list: D005353:Fibronectins; D005782:Gels; D046911:Macromolecular Substances; D005337:Fibrin; D005340:Fibrinogen; D005176:Factor XIII; D011503:Transglutaminases; D012103:Batroxobin; D013917:Thrombin